A possible role for antibodies to tumour necrosis factor alpha and to endotoxin in the treatment of Reye's syndrome.
Open Access
- 1 September 1995
- Vol. 37 (3) , 441-443
- https://doi.org/10.1136/gut.37.3.441
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Endotoxin and Tumor Necrosis Factor-α in the Pathogenesis of Hepatic EncephalopathyJournal of Clinical Gastroenterology, 1994
- Circulating interleukin-1 and tumor necrosis factor antagonists in liver diseaseHepatology, 1993
- Tumor Necrosis Factor Alpha Inhibits Hepatocyte Mitochondrial RespirationAnnals of Surgery, 1992
- Ca2+ responses to interleukin 1 and tumor necrosis factor in cultured human skin fibroblasts. Possible implications for Reye syndrome.Journal of Clinical Investigation, 1991
- Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.The Journal of Experimental Medicine, 1989
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- SERUM ACID PROTEOLYTIC ACTIVITY IN REYE SYNDROMEThe Lancet, 1987
- Reye's syndrome: Current conceptsHepatology, 1987
- IS REYE'S SYNDROME CAUSED BY AUGMENTED RELEASE OF TUMOUR NECROSIS FACTOR?The Lancet, 1986
- ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA A DISEASE ENTITY IN CHILDHOODThe Lancet, 1963